Insurance

Employers and advisers continue to evaluate the best-use scenarios for PBEs, says exchange head James Harmon.

The need to engage employees and navigate changing regulations creates opportunities for brokers to work with employers seeking HR tools and options.

From the ACA to employee classification, advisers can help small employers with a number of pressing regulatory issues.

Hospital market power, not technologies or regulation, is behind escalating prices, says benefits expert Joseph Jenkins, M.D.

The majority of employers expect the importance of non-traditional benefits to grow over the next three to five years, fueled in part by the changing demands of employees.

Hospital market power, not regulation or new medical technologies is behind escalating prices, says benefits expert Joseph Jenkins, M.D.

Nearly nine in 10 adults spend more than two hours each day using a digital device, all the more reason for employers to promote their vision plans.

The Strategic Insurance Agency Alliance partners with LifeLock to offer ID theft protection to employer-clients.

For employers, complying with the FMLA may feel like balancing on a tightrope. Here’s how advisers can assist their clients in managing the process.

Generic drugs are usually significantly cheaper for plan sponsors than brand-name drugs. Here’s a look at 10 drugs coming off patent in 2016. And although the FDA hasn’t yet approved generics for many of the following blockbuster drugs that are coming off patent this year, in most cases there are generics in the pipeline, according to Dickson Data Blog.